FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311348636> ?p ?o ?g. }

• W4311348636 endingPage "48058" @default.
• W4311348636 startingPage "48047" @default.
• W4311348636 abstract "Numerous therapeutic agents and strategies were designed targeting the therapies of Alzheimer’s disease, but many have been suspended due to their severe clinical side effects (such as encephalopathy) on patients. The attractiveness for small molecules with good biocompatibility is therefore restarted. Epigallocatechin-3-gallate (EGCG), extracted from green tea, is expected to be a promising small-molecule drug candidate, which can remodel the structure of preformed β-sheet-rich oligomers/fibrils and then effectively interfere with neurodegenerative processes. However, as the structure of non-fibrillary aggregates cannot be directly characterized, the atomic details of the underlying inhibitory and destructive mechanisms still remain elusive to date. Here, all-atom molecular dynamics simulations and experiments were carried out to elucidate the EGCG-induced remodeling mechanism of amyloid β (Aβ) fibrils. We showed that EGCG was indeed an effective Aβ fibril inhibitor. EGCG was capable of mediating conformational rearrangement of Aβ1–42 fibrils (from a β-sheet to a random coil structure) and triggering the disintegration of fibrils in a dose-dependent manner. EGCG redirected the structure of Aβ by breaking the β-sheet structure and hydrogen bonds between peptide chains within the Aβ protofibrils, especially the parallel β-strand (L17VFFAEDVGS26). Moreover, reduced solvent exposure and multisite binding patterns all tended to induce the conformation conversion of Aβ17–42 pentameric protofibrils, destroying pre-formed fibrils and inhibiting continued fibril growth. Detailed data analysis revealed that structural features of EGCG with abundant benzene ring and phenolic hydroxyl moieties preferentially interact with the parallel β-strands to effectually hinder the interaction of the interpeptide chain and the growth of the ordered β-sheet structure. Furthermore, experimental studies confirmed that EGCG was able to disaggregate the preformed fibrils and alter the protein structure. This study will enable a deeper understanding of fundamental principles for design of structural-based inhibitors." @default.
• W4311348636 created "2022-12-25" @default.
• W4311348636 creator A5007968044 @default.
• W4311348636 creator A5018194948 @default.
• W4311348636 creator A5029887153 @default.
• W4311348636 creator A5058272109 @default.
• W4311348636 creator A5058448344 @default.
• W4311348636 creator A5075986827 @default.
• W4311348636 date "2022-12-13" @default.
• W4311348636 modified "2023-10-18" @default.
• W4311348636 title "Structural Remodeling Mechanism of the Toxic Amyloid Fibrillary Mediated by Epigallocatechin-3-gallate" @default.
• W4311348636 cites W1552188451 @default.
• W4311348636 cites W1966078827 @default.
• W4311348636 cites W1982277539 @default.
• W4311348636 cites W1986934575 @default.
• W4311348636 cites W1995017657 @default.
• W4311348636 cites W2029667189 @default.
• W4311348636 cites W2035266068 @default.
• W4311348636 cites W2038532826 @default.
• W4311348636 cites W2048940684 @default.
• W4311348636 cites W2057477511 @default.
• W4311348636 cites W2067174909 @default.
• W4311348636 cites W2068834560 @default.
• W4311348636 cites W2069123478 @default.
• W4311348636 cites W2079872193 @default.
• W4311348636 cites W2110498021 @default.
• W4311348636 cites W2122294662 @default.
• W4311348636 cites W2127497004 @default.
• W4311348636 cites W2128572087 @default.
• W4311348636 cites W2131288855 @default.
• W4311348636 cites W2141920771 @default.
• W4311348636 cites W2313989869 @default.
• W4311348636 cites W2499136986 @default.
• W4311348636 cites W2620672869 @default.
• W4311348636 cites W2745090873 @default.
• W4311348636 cites W2747924829 @default.
• W4311348636 cites W2754854078 @default.
• W4311348636 cites W2757772641 @default.
• W4311348636 cites W2770601688 @default.
• W4311348636 cites W2772750159 @default.
• W4311348636 cites W2782483316 @default.
• W4311348636 cites W2795571682 @default.
• W4311348636 cites W2797893742 @default.
• W4311348636 cites W2801629100 @default.
• W4311348636 cites W2810943981 @default.
• W4311348636 cites W2884933563 @default.
• W4311348636 cites W2889496071 @default.
• W4311348636 cites W2897283547 @default.
• W4311348636 cites W2913507544 @default.
• W4311348636 cites W2919170549 @default.
• W4311348636 cites W2923362583 @default.
• W4311348636 cites W2923621162 @default.
• W4311348636 cites W2924290921 @default.
• W4311348636 cites W2948150640 @default.
• W4311348636 cites W2949573765 @default.
• W4311348636 cites W2969258607 @default.
• W4311348636 cites W2972007077 @default.
• W4311348636 cites W2979584796 @default.
• W4311348636 cites W2990201855 @default.
• W4311348636 cites W2991202994 @default.
• W4311348636 cites W2991346024 @default.
• W4311348636 cites W2998118287 @default.
• W4311348636 cites W3011916941 @default.
• W4311348636 cites W3012272172 @default.
• W4311348636 cites W3015209482 @default.
• W4311348636 cites W3036075708 @default.
• W4311348636 cites W3132119146 @default.
• W4311348636 cites W3145704193 @default.
• W4311348636 cites W4211238543 @default.
• W4311348636 cites W4236805864 @default.
• W4311348636 doi "https://doi.org/10.1021/acsomega.2c05995" @default.
• W4311348636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36591187" @default.
• W4311348636 hasPublicationYear "2022" @default.
• W4311348636 type Work @default.
• W4311348636 citedByCount "1" @default.
• W4311348636 countsByYear W43113486362023 @default.
• W4311348636 crossrefType "journal-article" @default.
• W4311348636 hasAuthorship W4311348636A5007968044 @default.
• W4311348636 hasAuthorship W4311348636A5018194948 @default.
• W4311348636 hasAuthorship W4311348636A5029887153 @default.
• W4311348636 hasAuthorship W4311348636A5058272109 @default.
• W4311348636 hasAuthorship W4311348636A5058448344 @default.
• W4311348636 hasAuthorship W4311348636A5075986827 @default.
• W4311348636 hasBestOaLocation W43113486361 @default.
• W4311348636 hasConcept C12554922 @default.
• W4311348636 hasConcept C161624437 @default.
• W4311348636 hasConcept C185592680 @default.
• W4311348636 hasConcept C27523624 @default.
• W4311348636 hasConcept C2777192995 @default.
• W4311348636 hasConcept C2778004101 @default.
• W4311348636 hasConcept C34349673 @default.
• W4311348636 hasConcept C55493867 @default.
• W4311348636 hasConcept C62614982 @default.
• W4311348636 hasConcept C70899900 @default.
• W4311348636 hasConcept C86803240 @default.
• W4311348636 hasConceptScore W4311348636C12554922 @default.
• W4311348636 hasConceptScore W4311348636C161624437 @default.
• W4311348636 hasConceptScore W4311348636C185592680 @default.

• next